אקסלון מדבקה 5

Country: Իսրայել

language: եբրայերեն

source: Ministry of Health

active_ingredient:

RIVASTIGMINE 4.6 MG/DAY

MAH:

NOVARTIS PHARMA SERVICES AG

ATC_code:

N06DA03

pharmaceutical_form:

PATCHES

administration_route:

TRANSDERMAL

manufactured_by:

NOVARTIS PHARMA STEIN AG, SWITZERLAND

therapeutic_group:

RIVASTIGMINE

therapeutic_indication:

Treatment of mild to moderate dementia of the Alzheimer's type.

authorization_date:

2013-11-01